Fetal Health assessment - PowerPoint PPT Presentation

About This Presentation
Title:

Fetal Health assessment

Description:

Piyawadee Wuttikonsammakit, M.D. Category I Category I fetal heart rate (FHR) tracings include all of the following: Baseline rate: 110 160 beats per minute ... – PowerPoint PPT presentation

Number of Views:1555
Avg rating:3.0/5.0
Slides: 80
Provided by: HP895
Category:

less

Transcript and Presenter's Notes

Title: Fetal Health assessment


1
Fetal Health assessment
  • Piyawadee Wuttikonsammakit, M.D.

2
Fetal surveillance
  • ???????????????????????? ??????????? 2 ????
  • ???????????? (antepartum fetal surveillance)
  • ???????? (intrapartum fetal surveillance)

3
Intrapartum fetal monitoring
4
Intrapartum fetal monitoring
  • Aims To identify the fetus at elevated risk for
    labor-related hypoxic injury so that clinicians
    can intervene to prevent or lessen that injury

5
Factors that may affect fetal oxygenation in
labor
6
Factors that may affect fetal oxygenation in
labor
7
Fetal surveillance during labor
  • Labour Support
  • Intermittent Auscultation
  • Admission Cardiotocography
  • Electronic Fetal Monitoring
  • Fetal Stimulation
  • Fetal Scalp Blood Sampling
  • Umbilicial Cord Blood Gases

8
New technologies
  • Fetal Pulse Oximetry
  • Fetal Electrocardiogram Analysis
  • Near-infrared spectroscopy
  • Intrapartum Scalp Lactate Testing

9
Labor support
  • Emotional support (continuous presence,
    reassurance, and praise)
  • Comfort measures (touch, massage, warm
    baths/showers, encouraging fluid intake and
    output)
  • Advocacy (communicating the womans wishes)
  • Provision of information (coping methods, update
    on progress of labor)

10
Continuous support for women during childbirth
  • 16 trials 13,391 women
  • slightly shorter labor
  • more likely to have a spontaneous vaginal birth
  • less likely to have intrapartum analgesia
  • less likely to report dissatisfaction with their
    childbirth experiences
  • Conclusion All women should have support
    throughout labor and birth.

Cochrane Database of Systematic Reviews 2007,
Issue 3
11
Intermittent auscultation
12
Recommendation frequency of auscultation
13
Admission cardiotocography
  • Labor admission tests EFM vs. IA
  • 4 RCTs including more than 13,000 women
  • Admission EFM more likely to have
  • increase in incidence of caesarean section
    relative risk (RR) 1.2, 95 CI 1.01.44,
    continuous EFM (RR 1.3 95 CI 1.41.48) and
    fetal blood sampling (RR 1.28 95 CI 1.131.45)
  • no significant differences in instrumental
    vaginal birth and fetal and neonatal death

Davane D, et al. Cardiotocography versus
intermittent auscultation of fetal heart on
admission to labour ward for assessment of fetal
wellbeing. Cochrane Database Syst Rev 2012 Feb
152CD005122.
14
Admission cardiotocography
  • ???? ???????? admission cardiotocography
    ????????????????????????????????? (low risk)
    ???????????????????????????????????????
    ??????????????????????????????????????????????????
    ????????????????????????????????????????
    (recommendation grade B)

15
Electronic fetal monitoring
16
Continuous CTG as a form of EFM for fetal
assessment during labor
  • 12 trials were included (over 37,000 women)
  • Results compared to IA, continuous EFM showed
  • no significant difference in overall perinatal
    death rate (RR 0.85, 95 CI 0.59 to 1.23)
  • a halving of neonatal seizures (RR 0.50, 95 CI
    0.31 to 0.80)
  • no significant difference in cerebral palsy (RR
    1.74, 95 CI 0.97 to 3.11)
  • a significant increase in C/S (RR 1.66, 95 CI
    1.30 to 2.13)
  • more likely to have an instrumental vaginal birth
    (RR 1.16, 95 CI 1.01 to 1.32)

Alfirevic Z. Continuous cardiotocography (CTG) as
a form of electronic fetal monitoring (EFM) for
fetal assessment during labour. Cochrane Database
of Systematic Reviews 2006, Issue 3. Art. No.
CD006066
17
Conclusion
  • Continuous cardiotocography during labor is
    associated with a reduction in neonatal seizures,
    but no significant differences in cerebral palsy,
    infant mortality or other standard measures of
    neonatal well-being.
  • However, continuous cardiotocography was
    associated with an increase in C/S and
    instrumental vaginal births

18
EFM recommendation
  • ???? ?????????????????????????????????????? (low
    risk) ?????????????????????????????????????
    (intermittent auscultation) ????????????? ??????
    continuous EFM ???????????????????????????????????
    ??????????????????????????????????????????????????
    ????????????????? (recommendation grade B)

19
EFM recommendation
  • 1. EFM is recommended for pregnancies at risk of
    adverse perinatal outcome.
  • 2. Normal EFM during the first stage of labor.
    When a normal tracing is identified, it may be
    appropriate to interrupt the EFM for up to 30 min
    to facilitate periods of ambulation, bathing, or
    position change, providing that (1) the
    maternal-fetal condition is stable and (2) if
    oxytocin is being administered, the infusion rate
    is not increased.

20
Pregnancy risk ? continuous EFM
  • Antepartum risk
  • PIH
  • GDM
  • Obesity
  • APH
  • Previous C/S
  • Twin
  • Breech presentation
  • Medical disease
  • Fetal risk
  • Intrapartum risk
  • APH
  • Prolonged PROM
  • Chorioamnionitis
  • Epidural block
  • Induction/augmentation of labor
  • Preterm labor
  • Postterm
  • Meconium stained ????????????????
  • ??????????????????????????????????????????????????
    ???

21
Fetal stimulation
  • Digital fetal scalp stimulation
  • Vibroacoustic stimulation

22
Digital scalp stimulation
  • An acceleration of 15 bpm amplitude with a
    duration of 15 sec has been shown to have a very
    high NPV (i.e., normal tracing) and very high
    sensitivity with regard to the absence of fetal
    acidosis.
  • It has been generally accepted that an
    acceleratory response is associated with a scalp
    pH of greater than 7.20

23
Recommendation
  • 1. Digital fetal scalp stimulation is recommended
    in response to atypical FHR tracings.
  • 2. In the absence of a positive acceleratory
    response with digital fetal scalp stimulation,
  • - fetal scalp blood sampling is recommended
    when available.
  • - if fetal scalp blood sampling is not
    available, consideration should be given to
    prompt delivery, depending upon the overall
    clinical situation.

24
Vibroacoustic stimulation for fetal assessment in
labor in the presence of a nonreassuring FHR
  • There are currently no RCTs that address the
    safety and efficacy of vibroacoustic stimulation
    used to assess fetal well-being in labor in the
    presence of a non-reassuring FHR.
  • Although vibroacoustic stimulation has been
    proposed as a simple, non-invasive tool for
    assessment of fetal well-being, there is
    insufficient evidence from RCTs on which to base
    recommendations for use of vibroacoustic
    stimulation in the evaluation of fetal well-being
    in labor in the presence of a non-reassuring FHR

East CE. Vibroacoustic stimulation for fetal
assessment in labour in the presence of a
nonreassuring fetal heart rate trace. Cochrane
Database of Systematic Reviews 2005, Issue 2.
Art. No. CD004664.
25
Fetal scalp blood sampling
  • If the pH is 7.20 or less, delivery is indicated
    because of the risk of fetal acidemia

26
Fetal scalp blood sampling
27
Recommendation
  • Where facilities and expertise exist, fetal
    scalp blood sampling for assessment of fetal
    acidbase status is recommended in women with
    atypical/abnormal fetal heart tracings at
    gestations gt 34 weeks when delivery is not
    imminent, or if digital fetal scalp stimulation
    does not result in an acceleratory fetal heart
    rate response.

28
Electronic fetal heart rate monitoring
  • NICHHD FHR interpretation guide

29
Electronic fetal heart rate monitoring
  • External (indirect) monitoring
  • Internal (direct) monitoring

30
External (indirect) monitoring
  • Doppler ultrasound for fetal heart rate
  • Tocodynamometer for uterine contractions

31
Internal (direct) monitoring
  • Direct application of fetal scalp electrode
  • Intrauterine catheter for pressure sensor

32
The 2008 National Institute of Child Health and
Human Development Workshop
33
Uterine contractions
  • Frequency every 3- 5 min, averaged over 30 min.
  • Duration optimal 30- 60 sec.
  • Other factors such as intensity, relaxation time
    between contractions

34
Terminology to describe uterine activity
  • Normal 5 contractions in 10 min, over 30 min
    window
  • Tachysystole 5 contractions in 10 min, over 30
    min window
  • Tachysystole presence or absence of associated
    FHR decelerations
  • The terms HYPERSTIMULATION/ HYPERCONTRACTILITY
    are not defined and should be abandoned

35
Abnormal uterine contractions
  • Dysfunctional labor
  • - Irregular contractions
  • - Low Fq, low duration/ low amplitude
  • Contractions threaten fetal well- being
  • - Tachysystole, prolonged contractions
  • Contractions threaten maternal well- being
  • - Extremely high amplitude- ut rupture
  • - High, sustained ut tone- abruptio placenta

36
FHR tracing
Full description requires
  1. Baseline rate
  2. Baseline FHR variability
  3. Presence of accelerations
  4. Periodic or episodic decelerations
  5. Changes or trends of FHR patterns overtime

37
Definitions of FHR patterns
Baseline FHR
  • Mean FHR rounded to increments of 5 beat/min
    during a 10-minute segment excluding
  • Periodic of episodic changes
  • Periods of marked FHR variability
  • Segments of the baseline that differ by gt 25
    beats/min
  • In any 10-minute window the minimum baseline
    duration must be at least 2 minutes

38
Definitions of FHR patterns
Baseline FHR
  • Normal 110-160 beats/min
  • Bradycardia lt 110 beats/min
  • Tachycardia gt 160 beats/min

39
Baseline FHR
40
Bradycardia
41
Tachycardia
42
CAUSES
  • Fetal bradycardia
  • Severe/ acute fetal hypoxemia
  • Fetal arrhythmia
  • Drug effect
  • Fetal tachycardia
  • Mild/chronic fetal hypoxemia
  • Maternal fever
  • Maternal hyperthyroidism
  • Fetal anemia/ heart failure
  • Fetal tachyarrhythmia
  • Drugs effect
  • Chorioamnionitis

43
Baseline FHR variability
  • Fluctuations in the baseline FHR of 2 cycles per
    minute or greater
  • Irregular in amplitude and frequency
  • Visually quatitated as the amplitude of the
    peak-to-trough in beats per minute

44
Baseline FHR variability
FHR variability Amplitude range (beats/min)
Absent Undetectable
Minimal lt 5
Moderate 6-25
Marked gt 25
Sinusoidal pattern smooth, sine wave-like
pattern of regular frequency and amplitude
45
Variability
46
Factors decreased FHR variability
  • Fetal behavior states inactive/ sleep
  • Medications narcotics, analgesics,
    tranquilizers, parasympatholytics
  • Abnormal CNS development extreme premature,
    anencephaly, severe hydrocephalus
  • Fetal hypoxia/ tachycardia

47
Accelerations
  • Visually apparent abrupt increase (defined as
    onset of acceleration to peak in lt 30 sec) in FHR
    above the baseline
  • gt 15 beats/min above the baseline, duration gt 15
    seconds and lt 2 minutes from the onset to return
    to baseline (GAgt32 wk)
  • gt 10 beats/min above the baseline, duration gt 10
    seconds

48
Acceleration
49
Prolonged acceleration Duration 2-10
min Acceleration Duration gt 10 min
Tachycardia
50
FHR deceleration
  • Late deceleration
  • Early deceleration
  • Variable deceleration
  • Prolonged deceleration
  • Recurrent deceleration occur 50 of uterine
    contractions in 20 min
  • Intermittent deceleration occur lt 50 of uterine
    contractions in 20 min

51
Late deceleration
  • Visually apparent gradual (defined as onset of
    deceleration to nadir gt 30 seconds) decrease and
    return to baseline FHR associated with a uterine
    contraction.
  • The nadir of the deceleration occurring after the
    peak of the contraction.
  • In most cases the onset, nadir, and recovery of
    the deceleration occur after the beginning, peak,
    and ending of the contraction, respectively.

52
Late deceleration
53
Early deceleration
  • Visually apparent gradual decrease (defined as
    onset of deceleration to nadir gt 30 seconds) and
    return to baseline FHR associated with a uterine
    contraction.
  • The nadir of the deceleration occurring at the
    same time as the peak of the contraction.
  • In most cases the onset, nadir, and recovery of
    the deceleration are coincident with the
    beginning, peak, and ending of the contraction,
    respectively.

54
Early deceleration
55
Variable deceleration
  • Visually apparent abrupt decrease (defined as
    onset of deceleration to nadir lt 30 seconds) in
    FHR below the baseline.
  • The FHR decrease from the baseline is gt 15
    beats/min, lasting gt 15 seconds, and lt 2 minutes
    from onset to return to baseline.
  • When variable decelerations are associated with
    uterine contractions, their onset, depth, and
    duration commonly vary with successive uterine
    contractions.

56
Variable deceleration
57
Variable deceleration
  • Typical variable deceleration
  • Transient pre and postacceleratory phase)
    shouldering
  • ?????????????????
  • ?????????????????????????????????????????

58
Variable deceleration
  • 1 normal shouldering
  • 2 overshoot
  • 3 loss of shouldering
  • 4 loss of variability
  • 5 late recovery
  • 6 biphasic deceleration

59
Variable deceleration
60
Prolonged deceleration
  • Visually apparent decrease in FHR below the
    baseline.
  • The decrease from the baseline is gt 15 beats/min,
    lasting gt 2 minutes, but lt 10 minutes from onset
    to return to baseline.
  • Prolonged deceleration of gt 10 minutes is
    bradycardia

61
Prolonged deceleration
62
Prolonged deceleration
63
Other patterns
  • Sinusoidal FHR pattern
  • Smooth sine wave- like with cycle Fq of 3- 5/min
    persists for 20 min

64
(No Transcript)
65
Quantification
  1. Any deceleration is quantitated by the depth of
    the nadir in beast per minute below the baseline
    (excluding transient spikes or electronic
    artifact). The duration is quantitated in minutes
    and seconds from the beginning to the end of the
    deceleration. Accelerations are quantitated
    similarly.
  2. Decelerations are tentatively defined as
    recurrent if they occur with gt 50 of uterine
    contractions in any 20- minute segment.
  3. Bradycardia and tachycardia are quantitated by
    the actual FHR in beats per minute, or the
    visually determined range if the FHR is not
    stable at one rate.

66
Three-Tier Fetal Heart Rate Interpretation System
  • Category I
  • Category I fetal heart rate (FHR) tracings
    include all of the following
  • Baseline rate 110160 beats per minute (bpm)
  • Baseline FHR variability moderate
  • Late or variable decelerations absent
  • Early decelerations present or absent
  • Accelerations present or absent

67
Three-Tier Fetal Heart Rate Interpretation System
  • Category II
  • Category II FHR tracings include all FHR tracings
    not categorized as Category I or Category III.
  • Category II tracings may represent an appreciable
    fraction of those encountered in clinical care.

68
Category II
  • FHR tracings include any of the following
  • Baseline rate
  • Bradycardia not accompanied by absent baseline
    variability
  • Tachycardia
  • Baseline FHR variability
  • Minimal baseline variability
  • Absent baseline variability not accompanied by
    recurrent decelerations
  • Marked baseline variability
  • Absence of induced accelerations after fetal
    stimulation

69
  • Periodic or episodic decelerations
  • Recurrent variable decelerations accompanied by
    minimal or moderate baseline variability
  • Prolonged deceleration 2 minutes but 10 minutes
  • Recurrent late decelerations with moderate
    baseline variability
  • Variable decelerations with other
    characteristics, such as slow return to baseline,
    overshoots, or shoulders

70
Three-Tier Fetal Heart Rate Interpretation System
  • Category III
  • Category III FHR tracings include either
  • Absent baseline FHR variability and any of the
    following
  • - Recurrent late decelerations
  • - Recurrent variable decelerations
  • - Bradycardia
  • Sinusoidal pattern

71
Category I (normal)
  • ??????????????????????????????????
  • Continue monitoring

72
Category II (indeterminate)
  • ????????????????? ???????????????
    ????????????????????? ???????????
    ?????????????????? ?????????????????????
    ???????????????????????????????????? (fetal pH)
    ????????????? acoustic stimulation
    ????????????????????????
  • ???????????? oxytocin
  • ??????????????????????????????????????????????????
    ????? ???? ???????????????????? ?????????????????

73
Category III
  • ??????????uteroplacental insufficiency
    ????????????????????????????? (fetal hypoxia)
    ?????????????????????? (acidemia)
  • ????????????????? ???????????????
    ????????????????????? ???????????
    ?????????????????? ?????????????????????
    ???????????????????????????????????? (fetal pH)
    ????????????? acoustic stimulation
    ????????????????????????
  • ???????????? oxytocin
  • ?????????????????????????? ????
    ???????????????????? ?????????????????

74
Quiz 1
75
Quiz 2
76
Quiz 3
77
Quiz 4
78
Quiz 5
79
Quiz 6
80
Quiz 7
81
Thank you
Write a Comment
User Comments (0)
About PowerShow.com